🚨GOOD NEWS🚨: some kids with leukemia can safely recover from intensive chemo at home instead of spending up to 6 months in the hospital over the course of their treatment! @chopresearch.bsky.social @ascocancer.bsky.social @pc3innovation.bsky.social @childrensphila.bsky.social

Thank you to Dr. Rob Winn of the @vcumassey.bsky.social Comprehensive Cancer Center for an incredible discussion on the importance of community in #cancercare research and delivery at the 2nd Annual Justin Bekelman Lecture in Cancer Care Innovation.

Please welcome new PC3I Faculty Stefan Barta, Associate Professor of Medicine at @upenn.edu! His research & clinical expertise lies in diagnosing, managing, & treating #lymphoma with a focus on identifying biomarkers & new therapeutic targets to improve outcomes. pc3i.upenn.edu/people/stefa...

Introducing new PC3I Faculty Angela Bradbury, Professor of Medical Ethics & Health Policy at @upenn.edu! Her research evaluates digital tools in genetic services including web-based interventions, chatbots, & #AI to reduce provider time & improve patient outcomes. pc3i.upenn.edu/people/angel...

Please welcome PC3I Visiting Faculty Christopher Booth, Professor of #Oncology & Public Health Sciences at Queen's University! His research focuses on access, quality, & value of #cancercare, specifically gastrointestinal cancers, in Canada & globally. pc3i.upenn.edu/people/chris...

Introducing new PC3I Faculty Rebecca Boswell, Clinical Associate Professor of Psychiatry at @upenn.edu! Dr. Boswell leads medical & psychological teams coordinating care across @pennmedicine.bsky.social, including #oncology, eating disorders, gastroenterology, & more. pc3i.upenn.edu/people/rebec...

Please welcome new PC3I Faculty Jie Deng, Professor of Nursing at @upenn.edu! Her research focuses on long-term #cancer survivorship, lymphedema management strategies, self-management in cancer survivors, and #healthcare delivery. pc3i.upenn.edu/people/jie-d...

Introducing new PC3I Fellow Henry K. Litt, a Fellow in Hematology/Oncology at @upenn.edu! He is interested in leveraging digital tools and #artificialintelligence to improve care delivery and decision-making for patients with #cancer. pc3i.upenn.edu/people/henry...

Join us in welcoming new PC3I Faculty Ryan Massa, Assistant Professor of Clinical Medicine at @upenn.edu! His research focuses on improving therapeutic strategies and access to high quality care for patients living with #cancer. pc3i.upenn.edu/people/ryan-...

Introducing PC3I visiting faculty Maija Reblin, Associate Professor at @uvmlarnermed.bsky.social! Her work focuses on understanding social contexts of advanced #cancer family caregivers & developing strengths-based interventions to support caregiver-patient dyads. pc3i.upenn.edu/people/maija...

Join us in welcoming new PC3I Faculty Aditi Singh, MD, Assistant Professor of Clinical Medicine at @upenn.edu! Her clinical & research interests focus on leveraging #healthinformatics and electronic health records to enhance care for patients with #cancer. pc3i.upenn.edu/people/aditi...

Introducing new PC3I Fellow Satvik Tripathi, a #RadOnc researcher at @upenn.edu! His research interests include using large language models & multimodal #AI to support clinicians & pts through innovations in structured reporting, patient education, & care navigation. pc3i.upenn.edu/people/satvi...

Join us in welcoming Teja Voruganti, MD, PhD, a #Hematology/Oncology Fellow at @penncancer.bsky.social! He is interested in studying #cancer treatment outcomes, patterns of care, & continuity of care to inform decisions affecting his own patients & those globally. pc3i.upenn.edu/people/teja-...

PC3I Program Director @rsedhom.bsky.social spoke with @realbowtiedoc.bsky.social about the benefits & nuances of Precision #PalliativeCare, which focuses on a patient's needs & preferences rather than diagnosis alone. Listen to the podcast episode from @ascocancer.bsky.social:

We are thrilled to welcome 6 new Faculty, 3 Fellows, and 2 Visiting Faculty to PC3I! Stay tuned over the next few weeks as we introduce each new member!

Patients with prior authorization requirements are more likely to have their access to #chemotherapy interrupted- facing a 10-day delay on average. PC3I Faculty @michaelannica.bsky.social spoke with @nytimes.com on the effects of health insurers denying drug claims for patients.

A study led by PC3I's Kate Courtright measured Goal-Concordant Care, the highest quality of care, using clinical notes in medical records. Findings can inform automated text-based classification to improve efficiency & facilitate reliable measurement of GCC in serious illness research. (@jama.com)

A project led by PC3I Program Director @drlolafayanju.bsky.social & @upennprc.bsky.social is combining the Best Case/Worst Case framework with the comprehensive geriatric assessment to increase shared decision-making conversations & improve communication & care for older adults with #cancer.

ICYMI from our newsletter highlighting time-saving interventions: Implementing a rideshare service to ease access to #gynecologic #cancer care reduced commute times by 19.5 minutes per ride compared to those using public transportation. Led by PC3I Faculty Anna Jo Smith & Emily Ko

#ICYMI from our newsletter highlighting time-saving interventions: Implementing a pre-appointment text-based symptom reporting tool helped save patients w/ #cancer 30 minutes in wait time and 66 minutes in total care time. Led by PC3I Faculty Ronac Mamtani

Congratulations @LovaSunMD, Lauren Reed-Guy, Minh Than (@penncancer.bsky.social), Sadia Laisa, Alexandria Lange, @AVitorSouza & Obinna Uzosike (@pennmedicine.bsky.social) on being named 2025 @conquercancer.bsky.social Awardees! @pc3innovation.bsky.social @ascocancer.bsky.social tinyurl.com/3au68spn

In our Spring Newsletter, we highlighted work that creates & tests ways to streamline #cancercare delivery and save patients valuable time spent commuting to, waiting for, & receiving care. Read our full newsletter: mailchi.mp/2a3a03821bbd... Subscribe here: bit.ly/4kaQ18c

Several young celebrities announced #breastcancer diagnoses in the past year - reaffirming the rising rates among women under 50. PC3I Program Director @drlolafayanju.bsky.social spoke with @nbcnews.com, recommending that young women with symptoms go to centers experienced in breast imaging. #bcsm

#PC3IatASCO: Surbhi Grover & Katie Lichter compared the #environmental impacts of #radiotherapy in Brazil and external beam #radiation therapy in the U.S.; and explored how sustainable practices can promote equity & expand access. #ASCO25 @ascocancer.bsky.social meetings.asco.org/ab...

#PC3IatASCO: @gabealeixo.bsky.social, @rsedhom.bsky.social & Sam Takvorian evaluating implementation of the Practical #Geriatric Assessment & resulting #chemotherapy dose modification among older adults with #cancer. #ASCO25 @ascocancer.bsky.social meetings.asco.org/ab...

#PC3IatASCO: Lauren Hamel, David Dougherty & team testing the effectiveness of using a education & communication intervention app to mitigate #financialtoxicity in patients with #cancer. #ASCO25 @ascocancer.bsky.social meetings.asco.org/ab... pc3i.upenn.edu/news/...

#PC3IatASCO: Susan Domchek w/ PC3I's Kate Rendle & Peter Gabriel implemented nudges to increase #genetictesting for diverse populations of patients at risk for #breastcancer and #ovariancancer across @pennmedicine.bsky.social. #ASCO @ascocancer.bsky.social meetings.asco.org/ab...

#PC3IatASCO: Emily Ko, Anna Jo Smith & @guerraviswanath.bsky.social evaluated implementation of a patient-ambassador program to provide #GynecologicOncology clinical trial awareness & knowledge for patients. #ASCO25 @ascocancer.bsky.social meetings.asco.org/ab...

#PC3IatASCO: PC3I's Melina Marmarelis, Charu Aggarwal & team used an EMR-based nudge for #NSCLC molecular testing at time of 1st post-operative visit. Findings showed the nudges increased rate of #moleculartesting in patients. #ASCO25 #LungCancer #LCSM meetings.asco.org/ab...

#PC3IatASCO: PC3I's Allie Barz Leahy, Haley Newman, & ‪@kerrycoughlin.bsky.social‬ analyzed pt & caregiver-reported #financialtoxicity (FT) outcomes for #pediatric pts receiving CAR T therapy & found high prevalence of FT at time of infusion. #ASCO25 meetings.asco.org/ab...

PC3I Faculty, Fellows, & staff will present 32 abstracts this weekend at the 2025 @ascocancer.bsky.social Annual Meeting. PC3I's work focuses on delivering patient-centered care, addressing socioeconomic barriers in #oncology, & applying digital interventions to improve patient care. #ASCO25

Wrapping up #NCRM25: Implementing a #pediatric-specific tool to collect patient-reported outcomes (#PROs) on subjective symptoms following CAR T Cell therapy to inform an early warning system for #treatmenttoxicity. Led by PC3I Faculty Allison Barz Leahy

Continuing our #NCRM25 celebration: Identifying patient-reported outcome measures for social & behavioral determinants of health (#SBDOH) data collection to improve the equity & efficiency of care for patients with #breastcancer. Led by PC3I Program Director @drlolafayanju.bsky.social

The next project we're highlighting for #NCRM25 is the Telehealth Research Center of Excellence (TRACE). Penn TRACE, led by PC3I Director Kate Rendle, is 1 of 4 National Cancer Institute centers focused on advancing #telehealth research to improve cancer care & health outcomes.

Continuing our celebration of National Cancer Research Month #NCRM25: A text-based e-triage screening tool reduced wait times for patients with #cancer by 30 minutes and total care time by 66 minutes per encounter. Led by PC3I Faculty Ronac Mamtani.

Penn Medicine Princeton's Geriatric Oncology Program, led by PC3I Program Director @rsedhom.bsky.social, has earned a 2025 Innovator Award from the Association of Cancer Care Centers, recognizing it as one of the nation’s most impactful models for advancing equity, quality, & value in #cancercare.

The first initiative we're highlighting for @theaacr.bsky.social's National Cancer Research Month is G.I.F.T.T. Led by PC3I's Meredith Doherty, this project addresses cancer-related financial hardship by pairing financial navigation with guaranteed monthly income for low-income patients. #NCRM25

The Spring 2025 Robert L. Comis, MD #TranslationalScience Symposium has officially kicked off with a great talk by Dr. Charu Aggarwal of @penncancer.bsky.social @pc3innovation.bsky.social on Tumor-Informed and Tumor Uninformed #ctDNA Approaches for Minimal Residual Disease (#MRD) Detection.

Inspiring advice from keynote speaker Dr. Efrat Dotan of @pennmedicine.bsky.social @pc3innovation.bsky.social at our Spring 2025 Task Force on #CareerAdvancement Session: 1) have an open mind, 2) learn from failures, and 3) develop relationships with colleagues

After being diagnosed with Stage 4 #lungcancer three years ago, a local father can look to the future thanks to advanced biomarker testing & targeted drug therapy under the care of PC3I Faculty Christopher D'Avella. Michael Hu shared his story with @cbsphiladelphia.bsky.social. #cansky #oncosky

Thrilled to share that our team at Penn Medicine Princeton @pc3innovation.bsky.social received the 2025 ACCC Innovator Award for our Geriatric Oncology Program! accc-cancer.org/home/about/a... Older adults deserve care tailored to their needs—and we made it real! and scalable

May is National Cancer Research Month! At PC3I, we’re proud to support innovation that drives equity in #cancercare. Throughout the month, we’re highlighting five PC3I Faculty-led projects that bridge gaps in treatment for patients facing barriers to care. #NCRM #OncoSky #CanSky

An investigational viral immunotherapy nearly doubled survival for patients with advanced non small-cell #lungcancer who had poor responses to immune checkpoint inhibitor therapy. PC3I Program Director Charu Aggarwal discussed the results of her phase-2 study with @gohealio.bsky.social #NSCLC #LCSM

On the latest episode of the @atscommunity.bsky.social "Breathe Easy" podcast, PC3I Faculty Roger Kim spoke about his recent publication in @jama.com on annual #lungcancer screening adherence and diagnosis rates. #CanSky #LCSM Watch or listen to the full episode ⤵️

PC3I Program Director @drlolafayanju.bsky.social recently spoke with Cancer Network about potential initiatives to address racial disparities and other social barriers to receiving guideline-concordant #breastcancer care. #bcsm #Oncsky #cansky

Reminder to nominate yourself or someone else by April 18 to join PC3I's team of innovators in #cancercare! Learn more: pc3i.upenn.edu/get-involved...

At the 2025 American Society of Preventative Oncology (ASPO) Annual meeting, PC3I Director Kate Rendle presented her work on closing the gap in #cervicalcancer diagnosis & treatment in Botswana. Read more on Dr. Rendle's work: pc3i.upenn.edu/our-work/pro...

PC3I Program Director Charu Aggarwal joined @vamsivelcheti.bsky.social for a discussion on the role of ctDNA (circulating tumor DNA) in #lungcancer management. #lcsm #oncsky #cansky Listen to the podcast from @ascocancer.bsky.social:

A study led by PC3I Faculty Anna Jo Smith & Emily Ko & published in @biomedcentral.bsky.social found that a rideshare service reduced commute times to #gynecologiconcology appointments & improved #cancercare access for socially vulnerable patients. #gynonc #gynoncsm

PC3I is seeking change agents in #cancer care and delivery to join us as Faculty and Fellows for FY26! Learn more about the roles here: pc3i.upenn.edu/get-involved... Fill out this form to nominate yourself or someone else by April 18: redcap.med.upenn.edu/surveys/?s=C...